GlobeNewswire

Study 4 (1002-048) – LDL-C Efficacy Primary Endpoint

LDL_C Efficacy

Percent Change from Baseline after 12 Weeks of Dosing of Bempedoic Acid 180mg
Esperion Therapeutics, Inc.
Format

JPEG

Source

Esperion Therapeutics, Inc.

Downloads